Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$9.34 USD
-0.32 (-3.31%)
Updated Sep 24, 2024 04:00 PM ET
Pre-Market: $9.39 +0.05 (0.54%) 8:04 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.31 | -9.09% |
Earnings Summary
For their last quarter, Iovance Biotherapeutics (IOVA) reported earnings of -$0.34 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 8.11%. Look out for IOVA's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 32.61%.
Earnings History
Price & Consensus
Zacks News for IOVA
Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
IOVA: What are Zacks experts saying now?
Zacks Private Portfolio Services